Ignite Creation Date:
2024-05-06 @ 12:30 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03775486
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2018-11-27
Brief Title:
Study of DurvalumabOlaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer ORION
Sponsor:
AstraZeneca
Organization:
AstraZeneca